Industry / innovation partners

KRAS Has a New Contender. It Still Has to Earn Its Place.

Migraine Prevention Gets a Wider Door

Cyclospora Is Spreading. The Food Chain Still Has No Answer.

Menopause is a cardiometabolic checkpoint. Health systems still treat it like a hormone debate

China’s Biliary-Cancer Bet Has a Global Access Problem

Cardiology has too many dashboards. The danger is forgetting the patient

GLP-1 drug choice now affects cardiovascular outcomes. Access and reimbursement rules have not caught up

A CE Mark Is Not Access

MENA’s cardiometabolic crisis is a stability issue
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
